Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity

NCT07594093 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight or Obesity

Interventions

DRUG: REGN20934
DRUG: Placebo

Sponsor

Regeneron Pharmaceuticals